A detailed history of Truist Financial Corp transactions in Alector, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 14,425 shares of ALEC stock, worth $27,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,425
Previous 34,025 57.6%
Holding current value
$27,696
Previous $154,000 56.49%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.34 - $6.58 $85,064 - $128,968
-19,600 Reduced 57.6%
14,425 $67,000
Q2 2024

Aug 20, 2024

SELL
$4.19 - $6.23 $24,385 - $36,258
-5,820 Reduced 14.61%
34,025 $154,000
Q1 2024

May 10, 2024

SELL
$5.69 - $8.08 $32,962 - $46,807
-5,793 Reduced 12.69%
39,845 $239,000
Q4 2023

Feb 02, 2024

SELL
$3.77 - $8.39 $15,268 - $33,979
-4,050 Reduced 8.15%
45,638 $364,000
Q3 2023

Nov 14, 2023

SELL
$5.2 - $8.77 $60,866 - $102,652
-11,705 Reduced 19.07%
49,688 $321,000
Q2 2023

Aug 01, 2023

BUY
$5.86 - $7.93 $43,991 - $59,530
7,507 Added 13.93%
61,393 $368,000
Q1 2023

May 05, 2023

BUY
$5.85 - $9.84 $31,543 - $53,057
5,392 Added 11.12%
53,886 $333,000
Q4 2022

Feb 17, 2023

SELL
$6.88 - $9.55 $13,656 - $18,956
-1,985 Reduced 3.93%
48,494 $447,000
Q3 2022

Oct 26, 2022

BUY
$8.19 - $13.2 $10,098 - $16,275
1,233 Added 2.5%
50,479 $477,000
Q2 2022

Jul 22, 2022

BUY
$7.65 - $14.24 $86,070 - $160,214
11,251 Added 29.61%
49,246 $500,000
Q1 2022

Apr 22, 2022

BUY
$13.02 - $20.78 $45,166 - $72,085
3,469 Added 10.05%
37,995 $541,000
Q4 2021

Feb 14, 2022

SELL
$19.35 - $25.54 $1,896 - $2,502
-98 Reduced 0.28%
34,526 $713,000
Q3 2021

Nov 05, 2021

BUY
$21.65 - $39.49 $245,034 - $446,947
11,318 Added 48.56%
34,624 $791,000
Q2 2021

Aug 16, 2021

BUY
$15.5 - $22.48 $151,125 - $219,180
9,750 Added 71.92%
23,306 $485,000
Q1 2021

May 17, 2021

BUY
$14.84 - $22.23 $8,918 - $13,360
601 Added 4.64%
13,556 $273,000
Q4 2020

Feb 18, 2021

BUY
$9.4 - $16.7 $121,777 - $216,348
12,955 New
12,955 $196,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.